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Abstract
This study provides a detailed experimental and mathematical analysis of the impact of the initial pathway of definitive
endoderm (DE) induction on later stages of pancreatic maturation. Human embryonic stem cells (hESCs) were induced to
insulin-producing cells following a directed-differentiation approach. DE was induced following four alternative pathway
modulations. DE derivatives obtained from these alternate pathways were subjected to pancreatic progenitor (PP) induction
and maturation and analyzed at each stage. Results indicate that late stage maturation is influenced by the initial pathway
of DE commitment. Detailed quantitative analysis revealed WNT3A and FGF2 induced DE cells showed highest expression of
insulin, are closely aligned in gene expression patterning and have a closer resemblance to pancreatic organogenesis.
Conversely, BMP4 at DE induction gave most divergent differentiation dynamics with lowest insulin upregulation, but
highest glucagon upregulation. Additionally, we have concluded that early analysis of PP markers is indicative of its
potential for pancreatic maturation.
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Introduction
Diabetes affects over 20 million people in the US [1]. In diabetic
patients the body is unable to produce or properly use insulin. The
most common treatment for type I diabetes consists of exogenous
insulin supply. Other treatment alternatives include transplanta-
tion of cadaveric pancreas or isolated pancreatic islets [2], but the
main limitations remain in the lack of available donor tissue.
Human embryonic stem cells (hESCs) have been suggested as an
alternative transplantable cell source for treatment of diabetes [3].
However, exploitation of the full potential of hESCs requires a
robust protocol for generation of mature and functional cell types.
Pancreatic differentiation of hESCs has received considerable
attention over the last decade. While there has been some success
in deriving insulin (INS) positive cells from hESCs, typically the
differentiated cells are limited in yield and functionality [4]. Most
differentiation protocols involve a stage-wise directed differentia-
tion strategy that mimics stages of pancreatic organogenesis by
modulating pathways known to be involved in pancreatic
development [3]. The first critical stage of pancreatic differenti-
ation is the commitment to definitive endoderm (DE). Studies over
the last decade have established multiple alternate pathways for
DE induction of hESCs. While all of these alternate routes yield
efficient DE, it is not obvious how sensitive pancreatic maturation
will be to such early pathways of DE induction. Thus, the method
of DE induction remains somewhat arbitrary, being assessed only
by the presence of DE markers and not by its potential for
pancreatic maturation.
In this work we are addressing this issue by evaluating the
sensitivity of late stage pancreatic maturation on initial pathways
of DE induction. We induced DE differentiation of hESCs by
activation of the Nodal pathway through Activin A, in combina-
tion with modulation of one of the following pathways: WNT,
BMP, PI3K and FGF. All of these pathways have been identified
as key players at multiple stages of pancreatic development.
Activin A, a TGF-b family protein, has been long identified to
mimic nodal, which results in mesoderm and DE formation [5].
FGF plays critical roles in several stages of pancreatic develop-
ment. In the ventral pancreatic endoderm, FGF signaling comes
from the adjacent endothelial mesoderm and at high concentra-
tions specifies hepatic development at the expense of pancreatic
differentiation [6]. Conversely, in the dorsal pancreatic endoderm,
FGF signaling comes from the notochord and works as a sonic
hedgehog (SHH) inhibitor, therefore inducing expression of PDX1
and further pancreatic development [6]. Additionally, BMP4
signaling from the septum transversum acts synergistically with
FGF2 to induce hepatic differentiation at the expense of ventral
pancreas development [7]. However, BMP4 signaling has been
found to act synergistically with Activin and FGF2 to promote
mesendoderm differentiation in human pluripotent stem cells [8]
and has been used in combination with Activin for DE induction
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in pancreatic differentiation studies [9–11]. Similarly, inhibition of
WNT signaling by proximal mesoderm has been implicated in
proper pancreatic and hepatic progression from the foregut
[7],while activation of WNT induces mesendoderm formation in
pluripotent stem cells from mouse and human sources [12–14].
Lastly, PI3K was first reported as a negative regulator of cellular
differentiation, and its inhibition has more recently been linked to
proper endoderm formation under high nodal signaling conditions
[15]. Studies have also linked PI3K suppression at later stages with
proper endocrine specification [16].
Due to the high complexity of these pathways and their role in
pancreatic progression, a more thorough analysis of their effects is
needed. The aim of this study is to compare previously identified
pathways of DE induction, analyze their pancreatic potential,
compare differentiation of these derivatives with existing reports
on in vivo pancreatic organogenesis and identify markers that can
be useful indicators of pancreatic differentiation at early stages of
the differentiation program.
Materials and Methods
hESC Maintenance
H1 hESCs (WiCell) were maintained in feeder free conditions as
previously described [17].
Pancreatic Differentiation Protocol
Once hESCs reached an average colony size of 1 mm in
diameter, DE induction media was added for 4 days with media
change every day. After 4 days media was replaced with
pancreatic progenitor (PP) media for 2 days with media change
every day. After 2 days, all-Trans Retinoic acid was added to the
PP media for 2 additional days with media change every day.
Media was then replaced with maturation media. After 2 days
DAPT was added to maturation media. Cells were maintained in
this media for 1 week with media change every day. Media
formulations are found in table S1.
Proliferation and Cell Death Quantification
On day 0 of the protocol, several wells were treated with
Accutase and starting cell density was estimated using a
hemocytometer. 24 hours after initial DE media exposure, cell
death was quantified by counting floating cells in the media and
normalized with respect to the starting cell density. Additionally,
the remaining attached cells were harvested with Accutase, stained
with propidium iodide in PBS at a concentration of 10 ug/ml and
the number of dead cells (PI positive) was quantified by flow
cytometry. For quantification of cell number throughout the entire
protocol, cells were exposed to alamar blue at day 0 according to
manufacturer’s instructions for quantification of cell number. This
procedure was repeated at the end of each stage of differentiation
(days 4,8,15), and cell number was calculated as described in the
product manual, using day 0 values as a control for each of the
stages.
Quantitative Polymerase Chain Reaction
qPCR was performed as previously described [11]. A list of the
primers used can be found in the table S2. DCt values were
calculated by subtracting the respective Ct value for GAPDH from
the Ct value of the marker(s) of interest. DDCt values were
calculating by subtracting the DCt values for undifferentiated cells
for the marker of interest from the DCt value for the same marker
in each group. Relative expression was found by calculating
22DDCt.
Flow Cyotometry
Flow cytometry was performed as previously described [11]. As
a control for non-specific staining, cells were incubated in
secondary antibody only. Cells were analyzed using an Accuri
C6 flow cytometer. Antibodies and concentrations can be found in
the table S3. For cell cycle analysis, cells were harvested and
dissociated with Accutase, rinsed, centrifuged and resuspended in
ice-cold 70% ethanol and fixed overnight in 220uC. Cells were
rinsed and suspended in DNA staining buffer (PBS+0.1% Triton-
X+0.2 mg/mL DNAse-free RNAse+0.01 mg/mL/1 million cells
propidum iodide) for 25 minutes at RT. Stained cells were then
directly analyzed on an Accuri C6 flow cytometer, the output of
which being a histogram of the DNA content for the cellular
population in each sample. To accurately determine the fractions
of the cellular population in each phase of the cell cycle from these
data, Modfit LT was applied to the DNA histogram data. Modfit
identifies the G1 and G2 peaks of DNA histograms acquired by
flow cytometry and fits established cell cycle models to these peaks
in addition to the S phase ‘‘peak’’. The area under the curve is
calculated via this model, thereby obtaining relative proportions of
each cell cycle phase within the population.
Immunofluorescence
Cells were fixed using 4% parafolmaldehyde for 15 minutes at
room temperature and permeabilized using 0.25% Triton X-100
(TX) for 15 minutes. Blocking was performed in 10% donkey
serum in 0.05% TX for 30 minutes followed by primary antibody
incubation which was performed overnight at 4uC in blocking
buffer with primary antbodies. Secondary antibody incubation was
performed for one hour at room temperature in the dark with
appropriate antibodies diluted in blocking buffer. Nuclear staining
was performed by incubation with Hoescht stain in PBS for 5
minutes. Pictures were taken using Olympus IX81 inverted
microscope and Metamorph imaging software.
Statistical Analysis
Differentiation results are presented as averages of 6 separate
independent experiments. Error bars represent SEM. Kriskal-
Wallis test was used to determine statistical significant difference
between the DE induction treatments. Additional Mann–Whitney
U tests were used for post-hoc comparison with Bonferroni
correction of the a.
Mathematical Analysis
Principal Component Analysis (PCA). The gene expres-
sion data containing the dynamics of the differentiation markers
across the four stages of differentiation and the four conditions was
analyzed using PCA. The data was preprocessed by mean
centering and variance scaling across each transcription factor.
PCA was done on this data in MATLAB R2010 by using the
princomp option. It was found that the first two principal
components (PCs) explained greater than 67% of the variance in
the data for all the PC analyses performed. Therefore, two PCs
were retained in the final analysis.
Clustering techniques. k-means clustering was used to
identify transcription factors (TFs) that showed similar patterns
of expression across the four stages independently for each
condition. MATLAB function kmeans was used with correlation
distance as a metric for clustering. The quality of the resulting
clusters was judged by the Silhouette value (Si). A threshold of 0.6
was selected for Si, and the number of clusters k which gave all Si
values greater than 0.6 were determined. Hierarchical clustering
was done on the entire dataset (all conditions together) to further
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classify the dynamics. MATLAB functions pdist and linkage were
used to perform the analysis on the mean expression data and the
results were represented as a clustergram. The tree generated
using other linkage measures were found to be similar with a
cophenetic correlation coefficient greater than 0.9.
Partial Least Squares Regression (PLSR). PLSR was
performed to find which of the earlier markers showed the highest
correlation with INS upregulation. The gene expression data was
gathered in matrix, X. INS was chosen as the output, Y, and the
remaining transcription factors acted as the predictors. MATLAB
function plsregress was used. The data was mean centered and
variance scaled. The PLSR analysis results in a BETA vector of
coefficients which describes the following relation between Y and
X:
Y~X|BETAzResiduals
Here, BETA is a (n+1) dimensional vector with the first entry as
the intercept and the remaining n entries as the coefficients
denoting the linear dependence of INS on each TF.
Results
Pancreatic Differentiation of hESCs
A multi-stage directed differentiation protocol was used to
induce the hESCs to pancreatic lineage (Fig. 1). The first step was
to induce DE through multiple alternate pathways, which was
achieved by exposure to Activin in combination with one of the
four other growth factors and molecules that modulate alternate
pathways for DE induction.
While Activin alone can induce DE, it is typically combined
with different molecules to increase the efficiency of induction. In
pancreatic differentiation studies, DE is most commonly achieved
by combination of Activin A with WNT3A[13], BMP4[9], PI3K
inhibitor[18] or FGF2[19].
After 4 days of DE induction Activin A and other inducers were
removed and all groups were exposed to the same subsequent
signals as follows (Fig. 1): for PP induction Cyclopamine was added
alone for two days and in combination with retinoic acid for two
additional days; cells were then exposed to nicotinamide alone for
2 days and nicotinamide and DAPT for up to one week for the
maturation stage.
Pancreatic maturation of hESCs is sensitive to the initial
pathway of endoderm induction
Morphological examination of the matured cells exposed to
alternate DE induction pathways revealed heterogeneous popula-
tions of cells in all conditions (Fig. 2A) containing groups of
cobblestone like cells indicative of endoderm morphology;
however, PI3KI cells appeared to be larger than other groups.
To determine if this was attributed to cell confluence, and to
analyze the system more thoroughly, we studied proliferation,
apoptosis and dynamics of cell cycle under different induction
conditions. Cell death at DE stage was comparable for all
conditions except PI3K inhibition, which elicited high cell death
(Fig. 2B). This is evident in Fig. 2C which shows a drop in cell
number in PI3KI-DE. However, cell cycle dynamics (Fig. 2D–E)
confirm a proliferative population, with similar dynamics between
PI3KI and WNT3A conditions. Analysis of the cell cycle clearly
indicates a maturing population of cells, transitioning from a
dominant S phase to a dominant G1 phase, representative of
mature cells [20]. As expected, undifferentiated hESCs (time= 0)
have a short G1 phase as exhibited by a low sub-population
(,27%) in the phase, with subsequent increase in G1 residence
time with differentiation (Fig. 2D). While the residence times of the
S and G2/M phases are not expected to significantly change with
differentiation, the fraction of the population in these phases
decreases to compensate for the increased G1 phase (Fig. 2E, F).
Compared to the PI3KI and WNT3A conditions, the kinetics of
this transition, from dominant S to dominant G1, is very slow for
the BMP4 and FGF2 conditions during initial DE induction, as
exhibited by a small fraction of the population in G1 up until day 2
(Fig. 2D). The G1 population then increases until it reaches a level
comparable to the WNT3A and PI3KI conditions at the end of
DE induction (day 4). This is reflected in the proliferation data
(Fig. 2C) showing an almost identical behavior between WNT3A,
BMP4, and FGF2 at DE.
In order to confirm differentiation after DE induction,
immunofluorescence (IF) and flow cytometry for SOX17 and
FOXA2 was performed for all groups after 4 days of treatment.
Both transcription factors were found to be expressed in all groups
(Fig. 1A–D) with yield of FOXA2 positive cells ranging from 40–
90%. qPCR was performed to examine expression of stage specific
markers CXCR4, SOX17, FOXA2 and CER. As illustrated in
Fig. 3A, upregulation of these markers was obtained under all
differentiation conditions, with PI3KI consistently eliciting the
highest upregulation, achieving close to 50 fold increase in CXCR4,
400 fold increase in SOX17, 10 fold increase in FOXA2 and 500
fold increase in CER.
Upon pancreatic induction, all the induction conditions show
expression of PP marker PDX1 by IF (Fig. 1A–D). This was
further confirmed by qPCR for PDX1, which showed that with the
exception of BMP4, all other conditions strongly expressed PDX1
(Fig. 3B). A notable increase of other PP markers was also
observed, particularly ISL1. BMP4 treated cells, however,
consistently showed either comparable or lower upregulation of
PP markers than the other groups. BMP4 treated cells additionally
showed downregulation of PAX6.
At the last stage of differentiation, IF and flow cytometry
confirmed expression of C-peptide for all groups with yields
ranging from 9–24% (Fig. 1A–D). Detailed gene expression for
mature b cell markers (Fig. 3C) revealed the highest INS mRNA
upregulation under WNT3A and FGF2 conditions, both of them
achieving over 10,000 fold increase compared to undifferentiated
cells, with no statistical difference between them. While BMP4
condition showed the lowest (11 fold) upregulation of INS, it was
the highest in upregulation of GLUC mRNA (Fig. 3C). It is
noteworthy that there was considerable variability in the results
from the different experiments, as observed by the error bars,
attributed to population heterogeneity and variable response to
global inductive cues [21,22]. However, despite the variability, all
experiments consistently showed a similar trend where highest
insulin upregulation for every experiment was obtained in FGF2 of
WNT3A treated cells, while BMP4 consistently lead to insignif-
icant insulin upregulation. Results from individual experiments
can be found in figure S1.
The above analysis clearly indicates that the initial pathway of
endoderm induction plays a crucial role in subsequent maturation
of the cells towards pancreatic lineage.
Alignment of in vitro differentiation with in vivo
organogenesis
Research over the last decade has established the advantage of
directed differentiation of hESCs following the sequence of in vivo
development. Hence, there is an increased emphasis on aligning
the in vitro differentiation dynamics to in vivo organogenesis events.
Accordingly, we analyzed the alternate pathways of endoderm
Pancreatic Potential of Definitive Endoderm
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induction and subsequent maturation in the light of differentiation
dynamics.
Pancreatic development can be broadly divided into 7 stages,
each characterized by specific transcription factors. The first stage
is primitive gut endoderm (PGE), from which pancreas, lung,
thyroid, thymus, parathyroid, and liver are derived[23], followed
by prospective pancreatic endoderm (PPE) containing prospective
ductal, endocrine and exocrine pancreatic cells. The next step is
the pancreatic progenitor (PP) stage marked by the transient
expression of PTF1 and is followed by appearance of NGN3
expressing early endocrine progenitors (EEP). EEP develop into
endocrine progenitors (EP), from which all the islet cell types
develop, including a, b, c, d and e cells. From here disappearance
of NGN3 expression marks emergence of immature b- cells which
mature into functional, INS expressing b-cells[24]. To draw a
parallel to our 3-stage differentiation protocol, we combined
specific developmental stages as follows: DE stage includes
endoderm, PGE, and PPE; PP stage includes PP and EEP
induction; and the maturation stage includes EP induction,
immature b- cells and b- cell maturation. Fig. 4A illustrates a
qualitative measure of the expression patterns of stage specific
transcription factors across different stages of development as
gathered from literature [23,24]. Fig. 4 (B–E) presents parallel
transcription factor dynamics for hESC differentiation under
different DE induction conditions as observed in a representative
sample with INS expression closest to the mean. For the purpose of
this study, we defined presence of a marker as 10 fold or higher
upregulation as observed by qPCR in order to account for
experimental error. Overall the FGF2, WNT and PI3KI
conditions were found to exhibit similar trends as in vivo
development, only with some minor differences. For example,
PTF1 is known to be an early and transient marker of pancreatic
commitment, preceding PDX1 expression. While both FGF2 and
WNT conditions show a gradual increase in PTF1, under PI3KI
conditions PTF1 comes up very late even though PDX1 expression
is detected much earlier, even at the DE stage. On the other hand
PAX6, which is expressed early in a cells and later in the entire islet
[25], and has been suggested to be a key component of glucagon
secretion [26], is prominent in PI3KI conditions from an early
stage (DE) and increases with maturation. BMP4 condition,
however, was found to be an outlier, as it did not align with either
in vivo sequences or any of the other conditions.
BMP4 induced DE cells exhibit a divergent maturation
dynamics
Analysis by hierarchical clustering. In order to resolve the
differentiation dynamics further, we performed hierarchical
clustering of 15 stage specific transcription factors measured over
4 time points under the 4 DE induction conditions. Fig. 5A shows
a heat map of transcription factor dynamics. Hierarchical
clustering of the transcription factor dynamics identified four
clusters of TFs, of which the most striking was the one formed
under BMP4 induction (NKX2.2, PAX6, HNF6, PTF1, NKX6.1).
These factors were rapidly down-regulated with differentiation
induction, the highest expression being in the undifferentiated
cells. It is important to note that the data in Fig. 5A is presented as
relative expression; hence, even though the absolute gene
expression for undifferentiated cells were the same under all
conditions, the differences in the heat map arises from the
normalization. Additional graphs illustrating expression patterns of
each individual marker are shown in figure S2. The aforemen-
tioned cluster branched separately from all of the remaining
clusters indicating the difference in transcriptional activation
following BMP4 treatment. Overall, many of the PP markers were
higher at the DE stage under BMP4 treatment while the later
markers were not upregulated upon maturation. On the other
hand, FGF2, WNT3A, PI3KI treatments followed the pancreatic
organogenesis closely as shown by clusters 2 to 4. On closer
inspection, it was found that 67% of the markers assayed for are
regulated in a similar manner under FGF2 and WNT3A pathway
modulation, representing the largest similarity between the
pathways studied. PI3KI leads to 47% and 40% similarity with
WNT3A and FGF2 respectively, and the 3 pathways regulate 33%
of the genes in a similar way. BMP4 treatment results in the most
dissimilar gene patterning, sharing only 7% similarity with FGF2
and 20% with both WNTA and PI3KI. Additionally, the
magnitude of upregulation of genes assayed for, including INS,
was comparable for the FGF2 and WNT3A conditions at all stages
of differentiation. Taken together, these results suggest similarity in
pancreatic maturation stages when FGF and WNT pathways were
modulated for initial endoderm differentiation.
In the hierarchical clustering formulation, each of the markers
was treated separately under each induction condition giving rise
to a total of 60 marker-condition pairs. However, in order to
compare the dynamics of differentiation, it will be advantageous to
look at the dynamics in the same space of transcription factors.
Hence, we projected each of the induction condition in the same
space of the transcription factors using principal component
analysis (PCA). However, PCA extracts new orthogonal directions
from the original space which are combinations of these markers.
Examination by principal component analysis. PCA
allows visualization of multidimensional data in a new orthogonal
coordinate space of PCs, and often the first few PCs explain most
of the variation in the data. In our case, we found that the first two
components explained 67% of the variation in the data, which is
significant for biological systems as the remaining variability can
often be attributed to noise. Fig. 5B shows a biplot where the time
points for each of the four induction conditions are plotted in the
PC space with the original variables (TFs) overlayed onto the plot.
The first PC divides the region into the undifferentiated state (III)
and differentiated state (I & IV). The second PC further splits it
into early markers (I & II) and the late markers (IV). Ideally, to
mimic pancreatic development, the cells must proceed from the III
quadrant (undifferentiated state) to IV (mature hormone express-
ing cells) via I (DE stage). Except BMP4, all the other induction
methods closely follow this path. It is found that WNT3A and
FGF2 follow similar paths ending up closer to the INS and GLUC
axes while PI3KI deviates significantly. PI3KI treatment still
favors the DE markers like SOX17 and FOXA2 and some late
markers like PAX6, HLXB9 and PDX1 during the final stages.
However, PI3KI derivatives fail to perform well with respect to the
important mature markers like INS and GLUC. BMP4 derivatives
perform very poorly with respect to INS expression, which is
Figure 1. Multi-stage Differentiation System. (A) Schematic representation of multi-stage differentiation system. Detailed media formulation
found in Supp table 1. DE was induced by modulation of nodal pathway simultaneously with one of four alternate pathways. PP was achieved by SHH
inhibition along with retinol signaling. Maturation was induced by notch inhibition. Differentiation using WNT3A (B), BMP4 (C), PI3KI (D) or FGF2 (E)
at DE stage. IF pictures show nuclear staining of SOX17 (green) and Flow cytometry shows yield of FOXA2 after DE induction, followed by nuclear
PDX1 IF pictures (purple) after PP induction and cytoplasmic C-Peptide IF (red) expression yield as measured by flow cytometry after maturation.
doi:10.1371/journal.pone.0094307.g001
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Figure 2. Cell Proliferation and Death Morphological analysis of the cells after (A) DE induction showing heterogeneous populations under all
conditions (Scale bar: 12.5 mM), and (B) Cell death after 24 h of DE treatment. Death was comparable in all groups, except for PI3KI which resulted in
considerably higher death (C) Increase in cell number was observed after DE and PP stage. Beyond the PP stage there is a slight decrease in cell
number for all conditions except PI3KI. (D–F) Cell cycle analysis of the differentiating cellular population under different conditions, as analyzed and
quantified by flow cytometry. Shown is the fraction of the population in the G1 (D), S (E), and G2/M (F) phases of the cell cycle. Data are represented
as mean +/2 STDEV.
doi:10.1371/journal.pone.0094307.g002
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accompanied by low expression of essential b-cell regulatory
factors such as PAX4 [27,28] (figure S3).
Diverse analysis of the experimental data leads to a similar
conclusion: BMP4 induction is less suitable for pancreatic b-cell
maturation. This is primarily because of low INS expression in the
mature phenotype along with lack of timely upregulation of
intermediate transcription factors known to be associated with b-
cell development. However, BMP4 treatment resulted in high
GLUC expression, although other associated a-cell markers were
not synergistically upregulated.
K-means clustering of individual pathways reveal WNT3a
to be more consistent with development
Our next goal was to determine which of the remaining
conditions are more suitable to drive pancreatic maturation. One
way to assess this is to find representative TFs that show coherent
expression dynamics. To address this question we scrutinized each
Figure 3. Stage Specific Marker Expression. Relative expression of (A) DE specific markers after DE induction under all differentiation
conditions. Upregulation was obtained for all groups with PI3KI consistently yielding highest expression. (B) PP specific markers after PP induction for
all DE derivatives with upregulation obtained for most markers under all conditions, except for BMP4 which consistently resulted in lowest
upregulation. (C) Pancreatic hormone expression after maturation for all groups with WNT3A and FGF2 groups achieving highest upregulation of INS
(p.0.05), while BMP4 obtained lowest INS upregulation but highest GLUC expression. Data are represented as mean +/2 SEM.
doi:10.1371/journal.pone.0094307.g003
Figure 4. Marker Progression. A representative sample (based on INS expression) for each group was analyzed and compared to in-vivo (A)
pancreatic development [24] in order to identify which DE pathway modulation(s) lead to better resemblance to pancreatic organogenesis.
Similarities can be observed when DE induction is achieved by modulation of (B) FGF2, (C) BMP4, (D) WNT3A and (E) PI3KI while we observed that
marker progression greatly differs under BMP4 induction. The different stages of pancreatic development were grouped to represent the 3 stages of
the differentiation protocol. Primitive gut endoderm (PGE) and prospective pancreatic endoderm (PPE) represent definitive endoderm induction
(light green) pancreatic progenitor (PP) and early endocrine progenitors (EEP) represent pancreatic progenitor induction (medium green) and
endocrine progenitors (EP), immature b- cells, mature b- cells (MC) represent the maturation stage (dark green).
doi:10.1371/journal.pone.0094307.g004
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Figure 5. Transcription factor dynamics. (A) Heat map for the entire data set of genes and conditions illustrating marker progression
throughout differentiation stages. The genes are organized according to the expression clusters found through hierarchical clustering. The
treatments are denoted on the right hand side as prefixes to the gene names. BMP4 induction condition typically was found to cluster separately
Pancreatic Potential of Definitive Endoderm
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of the pathways individually through K-means clustering of each
induction condition.
As shown in Fig. 6A, SOX17, FOXA2, HLXB9 were co-regulated
under WNT3A, FGF2 and PI3KI conditions. These markers
indicate the DE and dorsal pancreatic endoderm. This combina-
tion of SOX17, FOXA2 and HLXB9 was repeated in all the above
induction conditions, indicating that each of these treatments is
efficient for activating the primary DE transcriptional machinery
and that at the later stage transcriptional activation is different.
These markers were consistently expressed through all the
differentiation stages. In addition, PI3KI and FGF2 clusters also
contained ISL1. However, no other coherent cluster was obtained
for the PI3KI condition, indicating lower alignment with
developmental dynamics towards the later stages of maturation.
Additional clusters containing many later markers were
obtained for WNT3A and FGF2 as shown in Fig. 6B. One
among these was PTF1 and ISL1 under WNT3A which arise in
the pancreatic precursor cells during the early bud-stage. Other
late markers such as PAX6, PDX1, MAFA, GLUC, INS, NGN3,
HNF6, and NKX2.2, which are expressed in the NGN3+ cells
maturing to the b-cell stage [29], were also identified under
WNT3A treatment. These later markers show continuous rise in
expression across the stages. Therefore, it reinforces the observa-
tion that early WNT3A induced cells were found to closely shadow
the in vivo embryonic transcriptional dynamics. For FGF2, clusters
containing small number of late markers were identified as shown
in Fig. 6B. Two groups were identified, one containing PTF1 and
INS and the other containing HNF6, PAX6 and MAFA. However,
FGF2 contained far less coherent markers at the later stages than
WNT3A.
The above analysis indicates that modulation of Activin with
WNT and FGF2 are likely routes to pancreatic b-cells, although
WNT pathway is identified to be the most suitable because of the
co-regulation of important markers during each stage of the
differentiation process. Furthermore, this comparison reveals that
even though the expression of DE and PP markers are quite
similar for all the induction conditions at the end of DE stage, they
deviate significantly upon maturation. This is suggestive of cellular
‘memory’ of pathway of initial induction even after phenotypic
maturation.
from the rest. Hierarchical clustering was performed on the mean centered and variance scaled data of transcription factor dynamics across all the
four DE induction conditions. (B) Biplot of transcription factor dynamics assessed by principal component analysis on the mean data-set. The first
component shows a demarcation of the undifferentiated and differentiated states. The second component divides the markers according to their
expected appearance during in vivo differentiation. The PI3KI curve moves closer to the DE markers, BMP4 curve does not perform well and the
WNT3A and FGF2 curves show successful pancreatic maturation.
doi:10.1371/journal.pone.0094307.g005
Figure 6. Significant K-means clusters. Clusters obtained for each induction condition. (A) WNT3A (B) PI3KI (C) FGF2 and (D) BMP4. The
k-means clusters show close similarity of our induction conditions WNT3A and FGF2 with pancreatic organogenesis and PI3KI with definitive
endoderm commitment. The markers SOX17, FOXA2, HLXB9 are closely regulated under all the induction conditions.
doi:10.1371/journal.pone.0094307.g006
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PP markers, and not DE markers, are reliable predictors of
islet maturation
The above results establish that different pathways of endoderm
induction of hESCs have a significant influence on the cells’
subsequent mature phenotype and functionality. Another way of
looking at it is that efficiency of endoderm commitment, as
analyzed by current markers, is not indicative of an efficient
pancreatic maturation. The next question thus is whether any of
the early or intermediate stages can reveal the potential for cellular
maturation to islet cell types.
We addressed this by performing partial least squares regression
(PLSR) analysis on the mean TF expression data to identify which
early TFs, if any, were predictors of INS expression. Here we are
seeking the TFs that showed the most significant correlation to
INS expression over all the time points of the differentiation
trajectory. The correlation of each of the TFs with INS for each
induction condition is represented in Fig. 7 as associated regression
coefficients. It is found that most of the PP markers show high
degree of correlation to INS expression while there is no significant
dependence on the DE markers analyzed. None of the early DE
markers analyzed show a positive correlation to INS across all the
induction conditions. The intermediate PP stage markers,
including PTF1, PDX1, HNF6, NKX2.2, NKX6.1, and NGN3, are
better predictors of INS. Also, WNT3A and FGF2 conditions gave
positive coefficients with most of the PP and mature markers
indicating that these conditions are optimal for INS expression. It
is also observed that under BMP4 and PI3KI, the markers
NKX6.1, PTF1 and NGN3 gave strong positive correlations
indicating that these markers are in fact strongly associated with
INS even under low INS upregulation. In addition, we analyzed the
expression of PP markers after DE induction and found high
expression of HLXB9, PTF1 and ISL1 at this early stage under
some of the conditions for the selected sample. Interestingly, PTF1
resulted in high upregulation under FGF2 and WNT3A, which
resulted in highest INS upregulation. This observation, combined
with the fact that PTF1 expression is highly correlated to INS
expression under many conditions from PLSR, suggests that
analysis of PTF1 expression after DE induction could be used as a
determinant of pancreatic potential.
Discussion
This study analyzes and compares the potential of pancreatic
maturation of DE derivatives obtained from hESCs following
alternate pathways. Our primary goal was to determine if potential
for pancreatic maturation was sensitive to the pathway of initial
DE commitment, and if so, to determine which pathway is most
supportive of pancreatic maturation. In order to do so, we have
chosen the most commonly reported hESC cell line for pancreatic
differentiation (H1) for our analysis.
We chose to analyze those DE induction pathways which have
been most commonly reported in literature for pancreatic differen-
tiation of pluripotent stem cells. There have been reports of
successful DE induction following alternate routes which have not
been considered in the current study. For example, identification of
small molecules has shown great promise as a cost effective
alternative to expensive growth factors. While these molecules have
not been directly compared in our protocol, many of these molecules
modulate similar pathways as discussed here. Some examples
include 1m and CHIR99021 which act by inhibiting GSK3b
through WNT3A [30,31]; and IDE1 and IDE2 which modulate the
nodal pathway through activation of the TGF-b signaling pathway,
similar to Activin [32]. In addition, we have recently reported the
sensitivity of endoderm differentiation to substrate physical proper-
ties when cultured on fibrin [33] and alginate gels [34]. However, the
exact mechanism involved in such induction of differentiation
through insoluble cues has not yet been elucidated.
Importantly, we found that the yield of mature INS expressing
cells was sensitive to the pathways for initial DE induction. Our
analysis suggests that BMP4 signaling is not conducive for
pancreatic b-cell differentiation of hESCs. Even though other
studies have used BMP4 to achieve DE differentiation with
subsequent maturation to pancreatic lineage [8,9,35], in our
studies BMP4 derived DE derivatives were found to exhibit a
stronger potential for GLUC expression when subjected to our
maturation protocol. Several reasons could be attributed to this
Figure 7. Predictors of INS expression. Partial least squares regression performed on the mean expression. Most PP markers show high degree of
correlation to INS expression while there is no significant dependence on the DE markers. WNT3A and FGF2 conditions gave positive coefficients with
most of the PP and mature markers indicating that these conditions are optimal for INS expression. R2 values were above 0.995.
doi:10.1371/journal.pone.0094307.g007
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difference in the results. It is important to highlight that while these
studies also use BMP4 at early stages of differentiation, there are
obvious differences in the remaining differentiation protocol. Phillips
et al [8,35] reported the use of BMP4 in combination with Activin in
early stages of differentiation; however, in later stages they use FGF,
IGF, HGF, and VEGF, amongst other factors. Their differentiation
protocol is based on pancreatic differentiation from adult pancreatic
ductal cells, while our protocol is based on recapitulation of events
present during in vivo pancreatic organogenesis.
The earliest effect of BMP pathway modulation during
pancreatic development occurs at early DE development, where
in combination with Activin and FGF2, BMP4 signaling specifies
DE induction [8]. Also, at the earliest stages of differentiation,
BMP4 accelerates the downregulation of pluripotency genes and
upregulation of mesendodermal genes like BRACH [10]. However,
later effects of BMP4 are inhibitory of pancreatic differentiation
and strong inducers of hepatic differentiation [7]. In our
experiments we see BMP4 to consistently induce lowest upregula-
tion of DE, PP and mature b-cell markers which could indicate
residual BMP4 signaling from DE induction even after removal of
BMP4 from media. This is consistent with several pancreatic
differentiation studies that use BMP4 at DE induction stage, but
use noggin, a BMP pathway inhibitor, at later stages of
differentiation [35,36]. From marker progression analysis (Fig. 4)
we see that in BMP4 treated cells, NGN3 peaks early during DE
induction, with maintenance throughout the PP stage, and
decreases during the maturation stage. A recent study has
implicated temporal regulation of NGN3 as an important
determinant of cell type specification, with early expression
favoring a-cell induction [37]. In agreement with this, we also
see BMP4 cells do express highest levels of GLUC while exhibiting
a very low upregulation of INS and other essential b-cell markers,
including PAX4, NKX2.2 and NKX6.1[27,28,38]. These results
suggest that DE specification signaling may prime cells for a
particular mature endoderm cell type.
In a parallel work we tested possible combinations of growth
factors for inducing DE and found the combination of Activin,
FGF2 and BMP4 to give a high upregulation of SOX17 and CXCR4
compared to using FGF2 or BMP4 alone [17]. Recent work by Yu et
al. [39] gives an explanation for this effect, with FGF2 sustaining
Nanog expression and helping the BMP4 induced differentiation to
shift towards endoderm as opposed to extra embryonic lineages. In
a previous study by Vallier et al., using Activin in combination with
FGF2 and BMP4 resulted in similar differentiation into mesendo-
derm [40]. Based on this, we decided to mature the endoderm cells
derived under combination of FGF2 and BMP4 towards pancreatic
maturation. However, the level of INS upregulation upon matura-
tion remained comparable to that of BMP4 treatment alone (data
not shown). Thus, FGF2+BMP4 under high Activin seems to work
well for DE induction, but may not be optimal for further
maturation to the pancreatic lineages.
Our analysis further indicated modulation of WNT pathway to
be most supportive of pancreatic maturation. Several studies
establish the WNT canonical pathway as a potent endoderm
inducer and its presence has been shown to stimulate expression of
endoderm markers [24,41,42] while inhibition of the WNT
pathways induces increase of cardiac markers [43]. WNT is
therefore added during in vitro differentiation of hESCs particularly
during the initial stages of mesendoderm induction. The canonical
WNT pathway is found to cooperate with the Activin (SMAD)
signaling pathways for the expression of mesendoderm specific
genes [44]. However, WNT signaling must be suppressed at the
later stages during differentiation to the posterior foregut
endoderm [45,46]. Our results show WNT3A DE derivatives to
result in high INS expression levels and highest yield of C-peptide
positive cells. In agreement with this, in a previous study, Nostro et
al. found that at low concentrations, increasing canonical WNT
pathway activation at the endocrine development stage gave
higher upregulation of INS [35].
In addition, WNT3A and FGF2 shared most similarities in
terms of gene expression patterns and magnitudes, suggesting
similar transcriptional regulation. Also, the results of PCA showed
that the trajectory of differentiation was very similar for these two
conditions. Interestingly, both these conditions also lead to highest
expression of INS mRNA levels with no statistical difference
between them. While gene expression patterns were similar
between WNT3A and FGF2, cell cycle analysis reveals substantial
differences (Fig. 2). The length of the G1 phase for WNT3A
treated cells increased at a faster rate than for FGF2, as shown by
the higher proportion of the population in the phase. This longer
G1 phase time is indicative of a more mature phenotype [20,47].
Therefore, while both conditions give desirable mature gene
expression, WNT3A is the preferred route for maturation based
not only on gene expression but cell cycle behavior. The
conclusion that WNT3A leads to better pancreatic differentiation
potential is in agreement with a number of pancreatic differen-
tiation studies that use WNT3A in combination with Activin A at
the definitive endoderm stage, which have reported better yield,
insulin expression and functionality after in vivo maturation than
other pancreatic differentiation studies [3,13,14]. However, it is
difficult to identify the source of this variability since most of these
protocols are significantly different in terms of the growth factors
and reagents used along with reported cell lines. Our studies, in a
controlled platform, establish the significant effect of DE induction
pathway alone on the potential for cell maturation.
Finally, our results highlight the insufficiency in analyzing DE
markers at the DE stage as an adequate representation of cellular
maturation potential. In our experiments, PI3KI consistently
showed highest upregulation and yield of DE markers at the end of
the DE induction stage. However, upon maturation, its potential
for INS upregulation was lower than that of WNT3A and FGF2.
Our correlation analysis also supported this observation, where we
found the PP markers to correlate strongly with INS, but not the
earlier DE markers. This indicates that analysis of PP markers is
likely to give us information on the maturation potential of the
differentiating cells, but analysis of the DE markers alone is
unlikely to reveal such information. In addition, we suggest PTF1
expression analysis after DE induction to be a potential candidate
to determine pancreatic potential. PTF1 expression showed a high
degree of correlation to INS expression in our PLSR analysis.
Consequently, PTF1 expression appeared early in conditions
resembling pancreatic progression, where PTF1 expression
appears at the prospective pancreatic endoderm stage.
Conclusion
Multiple reports currently exist in literature on alternate
pathways for endoderm differentiation, yet the effect of the
pathway of endoderm commitment on late stage maturation, if
any, remains unexplored. In this study we conducted a systematic
investigation on the sensitivity of pancreatic maturation of hESCs
to the pathway of endoderm commitment. Late stage differenti-
ation was judged by gene expression levels of representative b-cell
markers, since the field is as yet limited in demonstrating
functionality of the hESC derived islet-like cells. This report
highlights the importance of the pathway of endoderm differen-
tiation - over efficiency of the differentiation - in shaping the
potential for further differentiation and maturation.
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